| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0008 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |